Extracellular matrix changes in corneal opacification vary depending on etiology by Módis, László et al.
The cornea is a unique six-layer avascular tissue of the 
human eye. Corneal transparency is essential for normal 
vision. In certain disorders, corneal transparency is lost due 
to tissue degeneration leading to irreversible stromal opacity 
with or without neovascularization. Conservative treatment 
may no longer be able to restore adequate eyesight warranting 
corneal transplantation. In bullous keratopathy (BK, Figure 
1A) and Fuchs’ endothelial dystrophy (FECD, Figure 1B), 
endothelial pathology is prominent [1,2], whereas in infec-
tious diseases, such as herpes simplex virus (HSV), keratitis 
corneal scarring with or without newly formed stromal 
vessels is evident.
The stroma is the thickest component of the cornea, 
full of extracellular matrix (ECM) fibers; therefore, the 
stroma is the most significant developmental challenge for 
transparency. The transparency of the stroma depends on the 
well-organized microstructure of the main building elements, 
such as collagen fibrils and different types of proteoglycans 
[3]. The most important collagens of the stroma are type I 
and type V fibrillary collagens, while the most character-
istic proteoglycans attached to them are decorin, mimecan, 
lumican, and keratocan [4]. The main significance of these 
proteoglycans is the regulation of interfibrillar space charac-
teristics and collagen fibril diameters [5]. Cells and molecules 
of the stroma form a unique and strictly organized network of 
approximately 60 lamellae. Because the rays of visible light 
are able to pass through, this fascinatingly delicate archi-
tecture is the key determinant of corneal transparency. The 
collagen fibrils taking part in the construction of this network 
are perpendicular to the corneal surface, are uniform in size 
(24–25 mm), and have regular spacing between them [6]. For 
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Purpose: The purpose of this study is to examine the expression of tenascin-C and matrilin-2 in three different disorders, 
which frequently require corneal transplantation. These pathological conditions include bullous keratopathy (BK), Fuchs’ 
endothelial corneal dystrophy (FECD), and corneal scarring in herpetic keratitis.
Methods: Histological sections of corneal buttons removed during keratoplasty were analyzed in BK (n = 20), FECD 
(n = 9), herpetic keratitis (n = 12), and cadaveric control (n = 10) groups with light microscopy following chromogenic 
immunohistochemistry. The sections were evaluated by three investigators, and semiquantitative scoring (0 to 3+) was 
applied according to standardized methods at 400X magnification. Each layer of the cornea was investigated; moreover, 
the stroma was subdivided into subepithelial, middle, and pre-Descemet’s membrane areas for more detailed analysis.
Results: Excessive epithelial and stromal expression of tenascin-C was identified in all investigated conditions; the 
results were most pronounced in the pre-Descemet’s membrane. Regarding matrilin-2, when examined in BK, there was 
increased labeling intensity in the epithelium (p<0.001) and stromal layers (p<0.05), and a decrease in the endothelium 
(p<0.001). In the other investigated conditions, only a low degree of stromal localization (p<0.05) of matrilin-2 was 
detected.
Conclusions: The expression of tenascin-C and matrilin-2 differs when examined in various corneal pathologies result-
ing in opacification. Both molecules seem to be involved in regeneration and wound healing of the corneal matrix in 
these diseases.
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light rays to cross through the corneal stroma, the undamaged 
structure of proteoglycans is also required [7].
Different alterations of the corneal ECM were observed 
in various conditions of the cornea affecting visual acuity. 
Ever since the microstructure of the stromal ECM was 
revealed, researchers have aimed to understand the altera-
tions of this structure to unveil the underlying biologic 
changes leading to corneal opacity. Many molecules, such 
as epidermal growth factor (EGF), platelet-derived growth 
factor (PDGF), transforming growth factor (TGF), fibroblast 
growth factors, different interleukins (ILs), tumor necrosis 
factor alpha (TNF-α), and different collagen types, have 
been investigated as possible participants in the emergence 
of corneal haze [8,9].
However, tenascin-C and matrilin-2 have not yet been 
thoroughly investigated in corneal diseases. Tenascin-C is 
a hexameric ECM glycoprotein with immediately increased 
expression in injury and infection. At the cellular level, 
tenascin-C is responsible for various dynamic cellular 
activities, such as cell adhesion, cell–ECM interaction, tissue 
remodeling, and proliferation [10-15].
Matrilin-2, however, is a member of the von Willebrand 
factor type A-like module superfamily [16]. The matrilins 
form a family of four, with each member binding to different 
types of collagenous and non-collagenous ECM structures, 
determining tissue stability via various interactions in the 
ECM [17]. Matrilins mainly mediate interactions between 
collagen-containing fibrils and other matrix constituents, 
such as aggrecan. Matrilin-2 has been thoroughly examined 
only in cartilage, muscle, and nerves, although this molecule 
is a crucial component of basement membranes throughout 
the body, including the corneal epithelial basement membrane 
[16-18].
The aim of this study was to examine the expression of 
tenascin-C and matrilin-2 in three different disorders, which 
frequently require corneal transplantation. Two of these 
conditions, BK and FECD, are similar in clinical presentation. 
The third, scar formation after HSV keratitis, is different, 
enabling us to compare diseases with different pathogenesis.
METHODS
Selection of patients and control corneas: Corneal buttons 
were obtained from 41 patients who underwent corneal trans-
plantation at the Department of Ophthalmology, University 
of Debrecen (Hungary). Most of the cases were patients with 
BK (n = 20, mean age 65.75±4.40 years), followed by patients 
with corneal scarring after HSV infection (n = 12, mean age 
53.33±7.70 years), and patients with FECD (n = 9, mean age 
67.33±5.10 years). Informed consent was not necessary due to 
the retrospective anonymized nature of the study on residual 
material.
Healthy corneas (n = 10, mean age 63.75±7.40 years) 
collected from cadavers (Department of Pathology, University 
of Debrecen) served as normal controls. These healthy control 
corneas were selected from cadavers in which previous ocular 
inflammation and surgical intervention could be ruled out. 
According to the referring regulation of ethics in Hungary, 
cadaveric tissue can be removed by presumed consent. In this 
case we applied the principle of presumed consent. The study 
was approved by the Institutional Scientific and Research 
Ethics Board (4468–2015). The use of tissue samples were in 
accordance with the Declaration of Helsinki.
Figure 1. Major clinical features of the investigated corneal diseases. In long-standing bullous keratopathy, the cornea becomes edematous 
and opaque. In the final stage newly formed vessels (arrow) penetrate the corneal tissue (A). In advanced forms of Fuchs' dystrophy the 
normal hexagonal endothelial cell monolayer on the posterior corneal surface is altered with a decrease in cell number (arrow), concomitant 
stromal edema and thickening (B). Stromal degeneration (arrow) after HSV infection. Some newly formed peripheral stromal vessels are 
also present (C).
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Laboratory procedures:
Preparation of histological slides—After removal, the 
corneas were immersion-fixed using a formaldehyde solution 
(pH = 7.4; 10% v/v) changed subsequently to paraformalde-
hyde (pH = 7.4; 4% v/v) overnight and then embedded in 
paraffin wax according to standard laboratory procedures. 
Seven-micron-thick sections were cut from the paraffin-
embedded blocks (Leica RM2245 microtome, Leica Biosys-
tems Nussloch Gmbh, Nussloch, Germany), coverslipped 
with DPX (BDH Laboratory Supplies, Poole, England), and 
left to dry overnight at room temperature.
Antibodies—For the immunohistochemical (IHC) reac-
tion, two types of antibodies were applied. For tenascin-C, 
mouse monoclonal antibody (DB7; ab86182, 1:50; Abcam, 
Cambridge, UK) in 1:50 dilution was used. For matrilin-2, 
rabbit polyclonal antibody (ARP57667_P050, 1:300; Aviva 
Systems Biology, Corp., San Diego, CA) was used in 1:300 
dilution with a standard overnight immunohistochemistry 
protocol [19].
Chromogenic immunohistochemistry: Chromogenic immuno-
histochemistry (CHR-IHC) was carried out as follows. After 
dewaxing and rehydration according to standard protocols 
[20], the endogenous peroxidase activity was blocked with 
Biocare Medical Peroxidazed 1 blocking reagent (Biocare 
Medical, Pacheco, CA) in Biocare Medical Peroxidazed 
diluent (Biocare Medical) diluted at 1:3, following the manu-
facturer’s instructions. Then heat-induced epitope retrieval 
was performed in a microwave oven (5 min at 800 W, 2 × 5 
min at 250 W) with sodium citrate buffer (pH = 6.0) as buffer 
solution. The non-specific IHC reaction was blocked with 1% 
(v/v) bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, 
MO) for 1 h at room temperature. The antibody dilution 
was 1:50 for tenascin-C and 1:300 for matrilin-2. Prelimi-
nary experiments were performed to establish the optimal 
antibody concentration and incubation time. As a result, the 
tenascin-C-treated sections were incubated overnight at 4 °C, 
while the matrilin-2-treated sections were incubated for 45 
min at room temperature. After the primary antibody was 
washed out with Tris-buffered saline (TBS; Sigma-Aldrich, 
TRIS-Buffered Saline 20x solution, 20 mmol Tris, pH 7.4), 
biotin-free secondary antibodies were added (MACH 4 
Universal HRP-Polymer, Biocare Medical) for 30 min at 
room temperature. After washing in TBS, for tenascin-C an 
immunoperoxidase technique was applied using 3,3′-diami-
nobenzidine tetrahydrochloride (DAB; Biocare Medical) as 
chromogen in humid chambers at room temperature. The 
matrilin-2-treated sections, however, were developed with 
alkaline phosphatase streptavidin, and alkaline phosphate 
substrate was used as chromogen. Then, the specimens were 
rinsed in running tap water for 10 min and in distilled water 
for 1 min.
Subsequently, the sections were treated with Harris’ 
hematoxylin as a nuclear counterstain. This step was followed 
by routine dehydration in ascending concentrations of ethyl 
alcohol solutions. Finally, the corneal buttons were covered 
with DPX mounting medium (Sigma-Aldrich) and were 
coverslipped manually.
Evaluation:
Semiquantitative scoring—Semiquantitative image 
analysis was performed by three authors of this article 
(MVL, GV, TH). A Nikon Eclipse 80i light microscope 
(Tokyo, Japan) was used at the magnification of 400X, and 
analysis was performed according to standardized methods 
of CHR-IHC assessment as described previously [21]. The 
semiquantitative scoring system had five scales (0, 0.5+, 1+, 
2+, 3+), where 0 means no staining (negative), 0.5+ minimal, 
1+ mild, 2+ moderate, and 3+ marked positivity (Figure 2). 
Every layer of the cornea was analyzed, even the acellular 
layers. In the epithelium and endothelium, 100 cells were 
counted in each section, and the arithmetic mean of the 
scores was calculated. In the other three layers (the Bowman’s 
membrane, stroma, and Descemet’s membrane), however, the 
general CHR sign intensity was established throughout the 
thickness of that particular layer. Because different layers of 
the stroma have different molecular characteristics and patho-
logical alterations [22], for evaluation the stroma was divided 
into three parts: subepithelial, middle, and pre-Descemet’s 
membrane.
Statistical analysis—We used SigmaPlot 12.0 software 
for Windows (Systat Software Inc., San Jose, CA) for statis-
tical analysis. The non-parametric data of differences in IHC 
sign intensity was assessed with the Mann–Whitney U-test; 
differences of p values of less than 0.05 were considered 
statistically significant.
RESULTS
Tenascin-C: We assessed the distribution of tenascin-C 
immunopositivity (Figure 3, Table 1). Control corneal 
buttons showed mild immunopositivity for tenascin-C in 
the corneal epithelium (the weighted arithmetic mean for 
tenascin-C scores in the intact corneas was 1.15, (Figure 3A). 
In this layer of the cornea, in BK, statistically significant 
immunoreactivity was detected (p<0.01) with a mean score 
of 2.00. The Bowman’s membrane was intensely stained 
in the control group, whereas the most pronounced posi-
tivity was noted in the stroma. In every subdivision of the 
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stroma, immunolabeling was unequivocally present in BK 
(p<0.001). Close to the Bowman’s membrane, the intensity 
was 1.50. The lowest value of tenascin-C expression was 
observed in the middle part of the corneal connective tissue 
(1.40), becoming more intense toward the pre-Descemet’s 
membrane region. The intensity peaked in the vicinity of the 
Descemet’s membrane (1.85). The DAB CHR signal strength 
of the endothelium was not statistically significantly above 
the intact corneal signal strength level (Figure 3B). In the 
corneas with FECD (Figure 3C), the epithelium and the 
Bowman’s membrane were shown to be statistically signifi-
cantly positive at the value of 1.67 (p<0.01). Noteworthy 
positivity in the stroma also occurred in the corneas with 
FECD. Although less intense than in the corneas with BK, 
a gradual elevation of the signal intensity toward the pre-
Descemet’s membrane part of the stroma was also character-
istic in the corneas with FECD (with semiquantitative scores 
of 0.88 in the subepithelial part, 1.00 in the middle part, and 
1.67 in the pre-Descemet’s membrane region). There were 
no changes in the expression pattern of tenascin-C in the 
endothelial layer. In the corneas with HSV keratitis (Figure 
3D), the most pronounced immunoreactivity (2.33) ensued in 
the epithelial layer (p<0.001). The Bowman’s membrane was 
unstained, and statistically significant labeling was detectable 
throughout the stroma (p<0.001). In contrast to the previous 
conditions, the endothelium was positive in the corneas with 
HSV keratitis (p<0.05).
Matrilin-2: We then assessed the distribution of matrilin-2 
immunopositivity (Figure 4 and Table 2.). No matrilin-2 
immunoreactivity (score 0.00) was evident in the control 
group in any layer of the corneal stroma; mild positivity was 
detected in the epithelium (1.30) and the endothelium (1.70, 
Figure 4A). In the corneas with BK (Figure 4B), intense 
(2.29) staining was noted in the epithelium (p<0.001) and 
mild positivity (0.30) in the pre-Descemet’s membrane divi-
sion of the stroma (p<0.05), whereas other divisions were 
unstained. The acellular layers also remained unstained, 
while in the endothelium moderate immunostaining was 
present regarding the control at a score of 0.71 (p<0.001). In 
the corneas with FECD (Figure 4C), the epithelium did not 
show immunopositivity, neither did Bowman’s membrane. 
The subepithelial (0.56) layer and the middle division (0.33) 
of the stroma stained for matrilin-2 (p<0.05), while the pre-
Descemet’s membrane (0.56) showed even more statistically 
significant positivity (p<0.01). In addition, Descemet’s 
membrane was stained (0.56) in the corneas with FECD with 
matrilin-2 (p<0.05). In the corneas with HSV keratitis (Figure 
4D), there was no immunostaining in the epithelium and 
endothelium or in the acellular layers. The only component 
of the cornea that showed positive reaction with the antigens 
was the stroma. All three layers exhibited the same level of 
statistical significance (p<0.05), with a value of 0.33 in the 
subepithelial, 0.33 in the middle layer, and 0.42 in the pre-
Descemet’s membrane.
Summarizing the results, the key finding was the 
statistically significantly elevated expression of tenascin-C 
in the epithelium and every layer of the stroma in all three 
investigated conditions. A statistically significant increase 
in tenascin-C expression was present in the Bowman’s 
membrane when examined in the corneas with BK and 
FECD. In the corneas with FECD, a notable increase was 
detected in the endothelium. In the corneas with BK, the 
expression level of matrilin-2 was statistically significantly 
elevated in the epithelium and the pre-Descemet’s membrane 
part of the stroma, and diminished in the endothelium. In the 
middle and pre-Descemet’s membrane stromal layer of the 
corneas with FECD and HSV keratitis, matrilin-2 showed an 
excessive presence compared to controls.
Tenascin-C revealed statistically significant differences 
only in the subepithelial stromal components when compared 
with the corneas with BK and FECD, whereas all other tissue 
layers showed similar staining intensity. Matrilin-2 stained 
differently in the epithelium (p<0.001), the Descemet’s 
membrane (p<0.05), and the endothelium (p<0.05).
Figure 2. The semiquantitative scoring system demonstrated on the epithelial layer None (0; A); minimal (0.5+; B); mild (1+; C); moderate 
(2+; D); marked (3+; E) immunopositivity.
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Figure 3. Tenascin-C immunohistochemistry. Control cornea: The epithelium, particularly the basal layer, shows mild immunopositivity 
(arrowheads). In addition, the endothelium (inset) shows a weak positivity regarding tenascin-C. Other components of the tissue are unstained 
(A). BK cornea: Tenascin-C is expressed moderately in the epithelium. An intraepithelial vesicle (star) is forming, which is characteristic 
of the disease. Bullae are present between the epithelium and Bowman layer (arrows). Intense expression appeared throughout the stroma, 
most prominently in the pre-Descemet region (arrowheads). Endothelial signal intensity (inset) does not differ significantly from the control 
(B). FECD cornea: In the basal cell layer of the epithelium intracellular oedema is detectable with increased tenascin-C expression (arrows). 
A vesicle is present between the epithelium and Bowman layer (star). Tenascin-C expression is mild throughout the stroma, however, with 
a gradual increase towards the pre-Descemet layer. The middle and the pre-Descemet region (arrowheads), respectively, differ from the 
control at a high level of significance (p<0.001; C). HSV keratitis cornea: The epithelium displays cellular and nuclear pleiomorpism and 
disorganization of layering. In addition, patchy loss of Bowman layer is revealed (arrow). Strong immunopositivity is present throughout 
the tissue, which is most prominent in the epithelium. The endothelium (inset) expressed more intensely tenascin-C as compared to the 
other investigated conditions (D). Insets: The endothelium of the control cornea and corneas affected by the studied disorders. Scale bars 
refer to 100 μm in the large figures and to 50 μm in the insets. Abbreviations: BK: bullous keratopathy; FECD: Fuchs' endothelial corneal 
dystrophy; HSV: herpes simplex virus.
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DISCUSSION
In the present study, we investigated the expression patterns 
of tenascin-C and matrilin-2 in three different diseases of 
high prevalence with corneal opacities: BK, FECD, and 
corneal scarring after HSV keratitis. The most conspicuous 
finding of the study was the statistically significantly elevated 
immunoreactivity for both antibodies in the posterior corneal 
stroma compared to healthy samples. This result was detected 
in all disorders. The epithelium also showed higher immu-
nopositivity (except tenascin-C in the corneas with FECD). 
The other striking feature we discovered was the statistically 
significantly higher matrilin-2 expression in the epithelium 
and the decreased expression in the endothelium when 
examined in BK cases compared to controls. In addition, the 
corneal endothelium disclosed mild immunopositivity in the 
investigated diseases.
Tenascin-C binds to numerous ECM components, cell 
membrane elements (syndecan 4, EGFR, contactin, integrin, 
annexin II), and soluble factors (VWF, different subtypes 
of FGF, PDGF, VEGF, PGF, BMP2, TGFβ 1 and 2) [10-15]. 
Through this large number of interactions, tenascin-C 
contributes to forming barriers, cues, niches, and tracks in 
the ECM, regulating the mechanical and adhesion interac-
tions in cell–ECM and cell–cell relations with an impact on 
intracellular signal transduction pathways. Due to tenascin-
C’s affinity for soluble factors, it may be a reservoir for these 
molecules [10]. Certain conditions induce persistent tenascin-
C production, such as chronic non-healing wounds, autoim-
mune diseases, cancer, and fibrotic diseases [11].
Concerning the cornea, higher tenascin-C expression 
was reported in BK [23], keratoconus [24], inflammation, 
fibrosis, and neovascularization [25]. Furthermore, the role 
of tenascin-C has been proven in corneal wound healing [26]. 
Tenascin-c and matrilin-2 proteins are expressed resolutely in 
lattice type I and granular stromal dystrophy [27].
Previous researchers documented excessive tenascin-C 
expression in the epithelium, basement membrane, subepithe-
lial layer, and pre-Descemet’s membrane part of the stroma 
in BK [23,28]. This was consistent with the present findings. 
Moreover, we found a similar pattern in FECD. Previous 
studies also disclosed tenascin-C immunopositivity in 
different corneal pathologies with inflammation [25], scar-
ring [25,29], and angiogenesis [30].
The most common characteristic clinicopathological 
finding in BK and FECD is corneal endothelial cell loss. This 
may serve as a possible explanation for the mild tenascin-
C immunopositivity in this corneal layer. The subsequent 
stromal edema usually progresses to the epithelium causing 
intra- and interepithelial edema. Finally, stromal degenera-
tion with loss of corneal transparency develops. This may be 
why the distribution of tenascin-C is similar in these three 
diseases. In addition, the much slower disease progression in 
FECD compared to BK is also consistent with the less intense 
epithelial immunopositivity.
These findings are similar to the processes we observed 
and demonstrated in the corneas with HSV keratitis. In such 
cases, the infection first manifests in the epithelium and 
then progresses deeper in the cornea. This explains why 
the highest tenascin-C immunopositivity was detected in 
the epithelium. The significant endothelial immunoposi-
tivity compared to controls may represent a strong adhesion 
between the Descemet’s membrane and endothelium after 
inflammation, as all surgical procedures were performed on 
a non-inflamed eye.
Matrilin-2, the non-collagenous basement membrane 
component, colocalizes with microfibrils and connects to 
fibrillin-2 [31]. The function of matrilin-2 is highly variable 
in the human body, including promotion of axonal growth and 
Schwann cell migration during peripheral nerve regeneration 
[32], modulation of dermal wound healing [33], and tumor 
development [34]. However, the role of matrilin-2 has rarely 
















BK 2.00 0.80 1.50 1.40 1.85 0.15 1.07
FECD 1.67 0.88 0.88 1.00 1.67 0.00 1.11
HSV 2.23 0.67 1.58 1.33 1.67 0.00 1.33
Control 1.15 0.22 0.30 0.25 0.35 0.15 0.70
The level of significance of the Mann–Whitney U-test is color-coded: white: not significantly different from the control; bold and italics 
font: p<0.05; bold font: p<0.01; italic font: p<0.001. (Minimum and maximum values are 0 and 3, respectively). Abbreviations: BK: bul-
lous keratopathy; FECD: Fuchs’ endothelial corneal dystrophy; HSV: herpes simplex virus keratitis.
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Figure 4. Matrilin-2 immunohistochemistry. Control cornea: Mild immunopositivity in the epithelium, most prominent in the basal layer 
(arrowheads) and moderate in the endothelium (inset). The stroma is immunonegative (A). BK cornea: The epithelial labelling is less 
pronounced and more evenly distributed (arrowheads) as compared to the control. The subepithelial and middle part of the stroma is 
unstained, the pre-Descemet region, however, shows mild immunoreactivity (arrows). The endothelium shows decreased staining intensity 
(inset) compared to the control (B). FECD cornea: The epithelium is thinner but does not show significant change in labelling intensity 
as compared to control. Disease-specific vesicles are present between the epithelium and the Bowman membrane (stars). Mild matrilin-2 
immunolabeling appears throughout the stroma, which is more prominent in the pre-Descemet region (arrowheads). Unlike in BK, the 
endothelium is stained sharply (C). HSV keratitis: The epithelium is irregular, the structure of the Bowman membrane is loose (arrows). 
There is delicate matrilin-2 expression in the subepithelial and middle part of the stroma, being more conspicuous in the pre-Descemet 
region (arrowheads). A blood vessel (star) invades the stroma indicative of pathological neovascularization (D). Insets: The endothelium of 
the control cornea and corneas affected by the studied disorders. Scale bars refer to 100 μm in the large figures and to 50 μm in the insets. 
Abbreviations: BK: bullous keratopathy; FECD: Fuchs' endothelial corneal dystrophy; HSV: herpes simplex virus.
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been investigated in human corneas, especially in patho-
logic conditions [27,31]. A recent paper disclosed elevated 
matrilin-2 levels in the corneal epithelium and stroma when 
examined in different corneal stromal dystrophies [27].
The present study demonstrated significant matrilin-2 
immunopositivity in the stroma compared to controls in all 
the investigated conditions. This result indicates the role of 
matrilin-2 in corneal ECM regeneration and wound healing. 
A key finding is the decreased endothelial and increased 
epithelial expression of matrilin-2 in BK cases. The role of 
matrilin-2 in epithelial reorganization, a process similar to 
wound healing in the corneal tissue, has been described [33]. 
During epithelial wound healing, the Bowman’s membrane 
usually degrades and is subsequently resynthesized. Together 
with chemotactic factor gradients, the Bowman’s membrane 
may regulate the migration of epithelial cells toward the site 
of injury [35]. This phenomenon could explain the increased 
matrilin-2 expression in the epithelium.
The presence of this protein in the corneal endothelium 
has not been studied previously; therefore, the decrease in 
matrilin-2 in BK cases is a new finding. The decreased expres-
sion might also be related to the role of endothelium in wound 
healing. When the endothelium is damaged, endothelial cell 
proliferation is a major mechanism in repair. However, this 
is of limited efficacy due to the low proliferative potential of 
human corneal endothelial cells [36]. Furthermore, matrilin-2 
is a cell adhesion molecule; therefore, the decrease in cell–
cell interactions due to cell loss is consistent with diminished 
matrilin-2 expression. Endothelial matrilin-2 expression may 
not only reflect the extent of endothelial injury but could also 
indicate its regenerative capacity. Overall, tenascin-C levels 
may serve as prognostic markers, and future studies should 
explore this.
BK may occur following intraocular surgical proce-
dures, most commonly cataract surgery. The key feature in 
the pathogenesis of BK is endothelial cell loss, which causes 
postoperative endothelial decompensation, leading to corneal 
edema and decreased vision. In addition, BK is a fertile 
terrene for the alternations of the ECM. Subepithelial fibrosis 
and a posterior collagenous layer in the stroma may also be 
observed in this condition. Older age renders the cornea more 
susceptible to BK, because the number of endothelial cells is 
diminished by aging. The iatrogenic endothelial injury and 
the compensatory stromal and endothelial reaction may be 
responsible for matrilin-2 alteration in BK, reflected by the 
altered basal membrane and microfibrillar structure at the 
cellular level.
In the investigated diseases, different changes occur in 
the corneal ECM concerning tenascin-C and matrilin-2. The 
well-structured stromal ECM is essential for visual acuity, 
and in corneal disorders, ECM changes resulting in fibrosis 
are responsible for decreased vision. Developmental studies 
revealed that tenascin-C is consistently present in neonatal 
corneas, whereas in adults it is limited to the limbus [37]. This 
was consistent with the present findings in healthy corneas 
because tenascin-C expression in the stroma was never higher 
than the IHC score of 0.40. In contrast, high stromal tenascin 
C expression was characteristic of all investigated patho-
logical conditions. The effect of altered tenascin-C on visual 
acuity has been described in BK [27], but the effects in FECD 
and HSV keratitis represent novel findings of this study.
It seems initial corneal edema leading to increased intra-
stromal pressure may be a shared feature in the pathomecha-
nism of the investigated disorders. Excessive fluid accumula-
tion in the stroma exposes keratocytes to mechanical stress. 
As a result, stromal keratocytes contract, stretching the 
surrounding collagen fibers [38]. This, according to studies 
on cultured fibroblasts, leads to excessive production of 
tenascin-C [15]. Because tenascin-C has adhesive properties, 
it may play an important role in mediating the reorganiza-
tion of stromal ECM components [38]. In parallel, matrilin-2 
secreted by keratocytes and fibroblasts is responsible for 
















BK 2.29 0.30 0.10 0.00 0.30 0.05 0.71
FECD 1.80 0.78 0.56 0.33 0.56 0.56 1.29
HSV 1.75 0.25 0.33 0.33 0.42 0.42 1.25
Control 1.30 0.20 0.00 0.00 0.00 0.00 1.70
The level of significance of the Mann–Whitney U-test is color-coded: white: not significantly different from the control; bold and italic 
font: p<0.05; bold font: p<0.01; italic font: p<0.001. (Minimum and maximum values are 0 and 3, respectively). Abbreviations: BK: bul-
lous keratopathy; FECD: Fuchs’ endothelial corneal dystrophy; HSV: herpes simplex virus keratitis.
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modulating ECM assembly and ECM–cell communication 
[39].
That both investigated molecules could be identified in 
the end stage of the most common corneal pathologies which 
finally require surgical intervention may be of great clinical 
relevance. These proteins seem to be involved in regeneration 
and reorganization of the corneal ECM either in degenerative 
(BK, FECD) or post-inflammatory corneal processes (scar 
formation after HSV keratitis). Better understanding of 
expression patterns and interactions of corneal ECM proteins 
in the context of pathogenesis and prognosis may pave the 
way for novel conservative therapy or less invasive surgical 
interventions in the treatment of corneal opacity. This is the 
main significance and the clinical relevance of the present 
findings.
Although in diseases with corneal opacification the gold 
standard treatment is penetrating keratoplasty, posterior 
lamellar transplantation is becoming more common in BK 
and FECD. Scraping of the Descemet’s membrane and the 
endothelium from the recipient before a healthy endothelial 
cell suspension is injected has shown promising results [40]. 
Furthermore, blocking extracellular high-mobility group 
box 1 in mice with corneal wounds successfully decreased 
the inflammation-mediated haze grade [41]. Tenascin-C and 
matrilin-2 may also become therapeutic targets for such less 
invasive procedures to treat corneal opacity.
In conclusion, tenascin-C and matrilin-2 are implicated 
in the pathogenesis of BK, FECD, and HSV keratitis with 
corneal scarring. Both molecules appear to be involved in 
regeneration and wound healing of the corneal matrix in these 
disease conditions. However, we detected substantial differ-
ences in immunolocalization regarding the different corneal 
layers. More studies are needed to further elucidate the role 
of these molecules in ECM regeneration and remodeling in 
relation to corneal opacification.
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